Jaguar Health (JAGX) Common Equity (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Common Equity data on file, last reported at -$15.8 million in Q1 2026.

• Common Equity for Q1 2026 came in at -$15.8 million, down 1997.83% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.8 million (down 1997.83% YoY), and the FY2025 annual result was -$18.7 million, down 387.77% from the prior year.
• Common Equity grew to -$15.8 million in Q1 2026 per JAGX's latest filing, from -$18.7 million in the prior quarter.
• Over five years, Common Equity peaked at $16.6 million in Q2 2024 and troughed at -$18.7 million in Q4 2025.
• A 5-year average of $3.4 million and a median of $4.9 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2026: Common Equity soared 824.93% in 2024, then sank 1997.83% in 2026.
• A 5-year view of Common Equity shows it stood at -$1.4 million in 2022, then jumped by 460.34% to $4.9 million in 2023, then soared by 32.61% to $6.5 million in 2024, then slumped by 387.77% to -$18.7 million in 2025, then rose by 15.71% to -$15.8 million in 2026.
• Business Quant data shows JAGX's Common Equity at -$15.8 million in Q1 2026, -$18.7 million in Q4 2025, and $4.4 million in Q3 2025.